| No. (%) |  | Mean ± SD or Median [IQR] (Range) |
---|---|---|---|
Total no. of CKRT runs per patienta | Â | Mean Dosec | |
 1 | 18 (81.8%) | Dialysate (mL/h) | 1800 |
 2 | 1 (4.5%) | Total Therapy Fluid (mL/h)d | 2000 |
 3 | 3 (13.6%) | Total Therapy Fluid/ABW (mL/kg/h) | 20.0 |
Total no. of SCUF runs per patienta | Â | Total Therapy Fluid/IBW (mL/kg/h) | 28.0 |
 0 | 19 (86.4%) |  | |
 1 | 2 (9.1%) | Median Prescribed Dosec | |
 2 | 1 (4.5%) | Dialysate (mL/h) | 1800 [1300–2300] (1000–5000) |
Anticoagulant Usedb |  | Total Therapy Fluid (mL/h)d | 2000 [1500–2500] (1200–5200) |
 None | 12 (54.5%) | Total Therapy Fluid/ABW (mL/kg/h) | 21.6 [17.6–25.2] (8.1–47.3) |
 Systemic unfractionated heparin (sUFH) | 7 (31.8%) | Total Therapy Fluid/IBW (mL/kg/h) | 28.8 [22.7–34.9] (14.1–69.3) |
 Prefilter (in-line) heparin | 4 (18.2%) |  | |
 Regional citrate anticoagulation (RCA) | 4 (18.2%) | Duration of CKRT runs (hours)a | 55.7 [17.5–84.5] (4–312) |
 Simultaneous combined sUFH + RCA | 4 (18.2%) |  |